| Medical applications of microarray technologies: a regulatory science perspective. | |
| | |
MedLine Citation:
|
PMID: 12454641 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The potential medical applications of microarrays have generated much excitement, and some skepticism, within the biomedical community. Some researchers have suggested that within the decade microarrays will be routinely used in the selection, assessment, and quality control of the best drugs for pharmaceutical development, as well as for disease diagnosis and for monitoring desired and adverse outcomes of therapeutic interventions. Realizing this potential will be a challenge for the whole scientific community, as breakthroughs that show great promise at the bench often fail to meet the requirements of clinicians and regulatory scientists. The development of a cooperative framework among regulators, product sponsors, and technology experts will be essential for realizing the revolutionary promise that microarrays hold for drug development, regulatory science, medical practice and public health. |
| | |
Authors:
|
Emanuel F Petricoin; Joseph L Hackett; Lawrence J Lesko; Raj K Puri; Steven I Gutman; Konstantin Chumakov; Janet Woodcock; David W Feigal; Kathryn C Zoon; Frank D Sistare |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Nature genetics Volume: 32 Suppl ISSN: 1061-4036 ISO Abbreviation: Nat. Genet. Publication Date: 2002 Dec |
Date Detail:
|
Created Date: 2002-11-27 Completed Date: 2003-01-08 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9216904 Medline TA: Nat Genet Country: United States |
Other Details:
|
Languages: eng Pagination: 474-9 Citation Subset: IM |
Affiliation:
|
Division of Therapeutic Products, Office of Therapeutics Research and Review, Center for Biologics Evaluation and Research, FDA, Bethesda, Maryland 20892, USA. petricoin@cber.fda.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Forecasting Genetics, Medical / trends Genomics / trends Humans Oligonucleotide Array Sequence Analysis / methods, trends* Policy Making Proteomics / trends Research / trends Technology Assessment, Biomedical United States United States Food and Drug Administration |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Microarray databases: standards and ontologies.
Next Document: Options available--from start to finish--for obtaining data from DNA microarrays II.